FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
01-21-2020, 01:53 PM | #1 | |||
|
||||
Grand Magnate
|
Not scientifically studied, but housing specifically designed to serve numerous Amyotrophic Lateral Sclerosis patients may prove to be the best treatment developed so far:
Leonard Florence Center for Living, Chelsea, Since 2010 Short Term Rehabilitation | Skilled Nursing Facility In Chelsea, MA Team Gleason House, New Orleans, since 2013 Team Gleason House | Team Gleason Similar projects under planning ALS Residence Initiative: Steve Saling Who is Steve Saling? - ALS RESIDENCE INITIATIVE (ALSRI) ALSRI (full web site) ALS RESIDENCE INITIATIVE (ALSRI) - www.ALSRI.org Medically recognized treatments vitamin e If supplements used for ten years, may reduce risk of developing Amyotrophic Lateral Sclerosis by about fifty percent. pulmonary pacer Placed at optimum time median advances possibly twenty-four months one study with weak results raised safety question, under review. Completed studies with published results: Moons Details 040 N=Σ- 0000 interpolated historical (most if not all were untreated) 056 iN=16 2004 Onders's Pilot (Onders's, et alia) protocol 041 N=43 2007 Onders's historical selection of (Lechtzin, et alia's, NonInvasive Ventilation study, June 2007) 062 iN=84 2011 SSPB {dataset submitted to FDA for HUD} (Onders's, et alia) protocol 031 iN=32 2012 DiPALS started weak side of (Onders's, et alia) protocol (late pacing, litmus) 049 N=37 2012 DiPALS per protocol standard of NonInvasive Ventilation care (only untreated 'team') 056 iN=36 2013 RespiStimALS started before NonInvasive Ventilation needed (early pacing, litmus) 146 iN=36 2013 RespiStimALS standard started within (Onders's, et alia) protocol RespiStimALS standard result very high . . . (based on electronic reports). non-invasive ventilation Properly used median advances possibly six months Riluzole When taken as directed median advances seventy-five days, plus or minus fifteen days. Radicava new, cross prescribe may help some patients. Deployment of computers Internet access widely valued by patients Google glass shows great potential Boston Dynamics robotics will be valuable |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
review of Prana Biotechnology mentions MND treatment | ALS News & Research | |||
Review of diagnosis of myasthenia gravis 12th october before and after treatment | Myasthenia Gravis |